Scott Rocklage is one of the most prominent figures in the healthcare and life sciences sector. He currently serves as the managing partner at 5AM Ventures and is based in Palm Beach Gardens, Florida. 5AM Ventures helps the new life sciences research and developing companies in the healthcare sector to get the investment they need to pursue their projects and investigations and attain mainstream importance. Scott Rocklage did his graduation receiving Bachelor in Science in Chemistry from the University of California, Berkeley. He did his Ph.D. in Chemistry from the world-renowned Massachusetts Institute of Technology. While at MIT, Scott Rocklage pursued his research in the laboratory of Nobel Prize Winner, Richard R. Schrock.
He has invented as well as co-invented many valuable items in the medical science and has over 30 patents in his name. The Food and Drug Administration of the United States has approved several medicines researched and developed by Dr. Scott Rocklage. Over the years, he has been highly active in the medical and healthcare research field and has served various important positions in different companies. Since 2004, Scott joined 5AM Venture Management LLC, where he started as a venture partner but went on to become the managing partner.
His experience of over three decades in the healthcare management led him to finally get the FDA approval of several drugs, namely Omniscan, Cubicin, and Teslascan. He has been associated with Salutar and Catalytica as a researcher and has served as the CEO of Cubist Pharmaceuticals. At Nycomed Salutar, he served as the President and CEO for many years. He was previously the chairman of the board at Novira and Relypsa. Other companies he serves as the board president includes Kinestral, Cidara, and Rennovia. At Epirus and Pulmatrix, he is one of the directors on the board.
The primary aim of Scott Rocklage today is to help the new and developing companies in the field of medical research and biotechnology to continue their growth and success. He, through his association with 5AM Ventures, identifies prospective businesses in the area of life sciences and makes an investment that does not only help the new companies but the healthcare service sector as well.